Diagnostic Approach to Hepatic Steatosis Beyond NAFLD

Introduction to Hepatic Steatosis

The American Gastroenterological Association recommends that clinicians systematically exclude alcohol-related liver disease, medications, viral hepatitis, and rare metabolic/genetic disorders before confirming a diagnosis of NAFLD 1, 2

Significant alcohol consumption is defined as >21 drinks per week in men or >14 drinks per week in women, which indicates alcohol-related liver disease rather than NAFLD 1, 3, 4
The American College of Gastroenterology suggests using sensitive biomarkers such as urine ethyl glucuronide or blood phosphatidylethanol when alcohol history is unreliable 1
The AUDIT-C questionnaire should be incorporated to standardize screening for alcohol misuse and binge drinking 2, 5

Approximately 2% of steatosis cases are attributable to prescribed medications, requiring a comprehensive drug history in all patients 2, 5
The European Association for the Study of the Liver recommends considering high-risk medications such as antiarrhythmics, anticonvulsants, anti-metabolites, hormone modulators, antiretrovirals, and analgesics 2, 5

Hepatitis C genotype 3 is specifically associated with increased rates of steatosis and must be excluded with viral serology in all patients undergoing evaluation for suspected NAFLD 1, 2, 5

The American Association for the Study of Liver Diseases suggests considering rare metabolic and genetic causes, such as lysosomal acid lipase deficiency, familial hypobetalipoproteinemia, and abetalipoproteinemia, particularly in lean individuals with steatosis who lack cardiometabolic risk factors 1
Wilson's disease and hemochromatosis should also be considered, with elevated ferritin and transferrin saturation warranting HFE gene testing 3, 4

A comprehensive metabolic and serological screen must be undertaken to consolidate the NAFLD diagnosis and exclude co-existent liver disease 2, 5
The American Gastroenterological Association recommends required laboratory evaluation, including autoimmune markers, viral serology, iron studies, copper studies, alpha-1 antitrypsin level, and thyroid function tests 1, 2, 5